---
$id: https://graph.org.ai/products/commodity/51241242
$type: Product
source: UNSPSC
code: "51241242"
title: "Crotamiton"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Crotamiton

**UNSPSC Code**: 51241242
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a topical anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D6S4O4XD0H. European Medicines Agency schedules Crotamiton in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06828MIG. Crotamiton generally arises in the molecular formula C13H17NO. The term CROTAMITON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, no. 12, 1959, list 3.) CROTAMITON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule crotamiton under HS 29242995 and SITC 51479. As of Q4 2014, CROTAMITON remains the US FDA Preferred Term for this commodity. Crotamiton bears US NLM identifiers UMLS ID C0056519 and NCI Concept Code C65353. SMILES: CCN(C1=CC=CC=C1C)C(=O)C=CC.

